Tersan Pharmaceuticals Ltd and Laboratoires Pierre Fabre have recently published the results of a clinical data mining study using KEM to identify the best responder subgroups for Milnacipran in fibromyalgia. “Is the Efficacy of Milnacipran in Fibromyalgia Predictable? A Data-Mining Analysis of Baseline and Outcome Variables”, Lilia Abtroun, PhD, Pierre Bunouf, PhD, Roger M Gendreau, MD, […]